Salta al contenuto principale
Farmacovigilanza
Form di ricerca
Ricerca
Home
Rivista
Casi
Newsletter
Link
Chi siamo
Contatti
News
Aprile 2022
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe
Aprile 2022
Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy Outcomes
Aprile 2022
Hypersensitivity Reactions to COVID-19 Vaccines—Identify High-Risk Children and Vaccinate the Rest
Febbraio 2022
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
Febbraio 2022
Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies
Febbraio 2022
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021
Gennaio 2022
A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination
Gennaio 2022
Analysis of COVID-19 Vaccine Type and Adverse Effects Following Vaccination
Gennaio 2022
Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA Vaccine
Dicembre 2021
New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine
Pagine
« prima
‹ precedente
…
3
4
5
6
7
8
9
10
11
…
seguente ›
ultima »
80.211.154.110
